Banks - Regional
Compare Stocks
2 / 10Stock Comparison
BMA vs GGAL
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
BMA vs GGAL — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Banks - Regional | Banks - Regional |
| Market Cap | $4.84B | $5.76B |
| Revenue (TTM) | $6.46T | $10.63T |
| Net Income (TTM) | $291.41B | $915.98B |
| Gross Margin | 68.3% | 62.7% |
| Operating Margin | 5.6% | 20.8% |
| Forward P/E | 0.0x | 0.0x |
| Total Debt | $465.41B | $2.16T |
| Cash & Equiv. | $2.78T | $3.76T |
BMA vs GGAL — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Banco Macro S.A. (BMA) | 100 | 448.5 | +348.5% |
| Grupo Financiero Ga… (GGAL) | 100 | 542.3 | +442.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BMA vs GGAL
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BMA is the clearest fit if your priority is dividends and momentum.
- 6.8% yield, 1-year raise streak, vs GGAL's 6.8%
- -6.5% vs GGAL's -22.8%
GGAL carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 0 yrs, beta 1.73, yield 6.8%
- Rev growth -23.5%, EPS growth 119.6%
- 76.7% 10Y total return vs BMA's 56.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -23.5% NII/revenue growth vs BMA's -33.3% | |
| Value | Lower P/E (0.0x vs 0.0x), PEG 0.00 vs 0.00 | |
| Quality / Margins | Efficiency ratio 0.4% vs BMA's 0.6% (lower = leaner) | |
| Stability / Safety | Beta 1.73 vs BMA's 1.76 | |
| Dividends | 6.8% yield, 1-year raise streak, vs GGAL's 6.8% | |
| Momentum (1Y) | -6.5% vs GGAL's -22.8% | |
| Efficiency (ROA) | Efficiency ratio 0.4% vs BMA's 0.6% |
BMA vs GGAL — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
BMA leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
GGAL is the larger business by revenue, generating $10.63T annually — 1.6x BMA's $6.46T. GGAL is the more profitable business, keeping 15.3% of every revenue dollar as net income compared to BMA's 5.0%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $6.46T | $10.63T |
| EBITDAEarnings before interest/tax | $620.9B | $1.35T |
| Net IncomeAfter-tax profit | $291.4B | $916.0B |
| Free Cash FlowCash after capex | -$2.44T | $3.62T |
| Gross MarginGross profit ÷ Revenue | +68.3% | +62.7% |
| Operating MarginEBIT ÷ Revenue | +5.6% | +20.8% |
| Net MarginNet income ÷ Revenue | +5.0% | +15.3% |
| FCF MarginFCF ÷ Revenue | +12.3% | -27.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | -136.4% | -138.6% |
Valuation Metrics
GGAL leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
At 5.1x trailing earnings, GGAL trades at a 76% valuation discount to BMA's 21.1x P/E. Adjusting for growth (PEG ratio), GGAL offers better value at 0.04x vs BMA's 0.41x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||
|---|---|---|
| Market CapShares × price | $4.8B | $5.8B |
| Enterprise ValueMkt cap + debt − cash | $3.2B | $4.6B |
| Trailing P/EPrice ÷ TTM EPS | 21.07x | 5.10x |
| Forward P/EPrice ÷ next-FY EPS est. | 0.01x | 0.01x |
| PEG RatioP/E ÷ EPS growth rate | 0.41x | 0.04x |
| EV / EBITDAEnterprise value multiple | 8.89x | 2.68x |
| Price / SalesMarket cap ÷ Revenue | 1.04x | 0.75x |
| Price / BookPrice ÷ Book value/share | 1.69x | 1.48x |
| Price / FCFMarket cap ÷ FCF | 8.49x | — |
Profitability & Efficiency
GGAL leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
GGAL delivers a 12.9% return on equity — every $100 of shareholder capital generates $13 in annual profit, vs $6 for BMA. BMA carries lower financial leverage with a 0.11x debt-to-equity ratio, signaling a more conservative balance sheet compared to GGAL's 0.36x. On the Piotroski fundamental quality scale (0–9), BMA scores 6/9 vs GGAL's 3/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +6.1% | +12.9% |
| ROA (TTM)Return on assets | +1.4% | +2.2% |
| ROICReturn on invested capital | +5.5% | +31.0% |
| ROCEReturn on capital employed | +5.5% | +19.5% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 3 |
| Debt / EquityFinancial leverage | 0.11x | 0.36x |
| Net DebtTotal debt minus cash | -$2.31T | -$203.1B |
| Cash & Equiv.Liquid assets | $2.78T | $3.76T |
| Total DebtShort + long-term debt | $465.4B | $2.16T |
| Interest CoverageEBIT ÷ Interest expense | 0.28x | 0.71x |
Total Returns (Dividends Reinvested)
BMA leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BMA five years ago would be worth $69,454 today (with dividends reinvested), compared to $65,574 for GGAL. Over the past 12 months, BMA leads with a -6.5% total return vs GGAL's -22.8%. The 3-year compound annual growth rate (CAGR) favors BMA at 70.7% vs GGAL's 59.5% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -11.6% | -17.7% |
| 1-Year ReturnPast 12 months | -6.5% | -22.8% |
| 3-Year ReturnCumulative with dividends | +397.7% | +305.9% |
| 5-Year ReturnCumulative with dividends | +594.5% | +555.7% |
| 10-Year ReturnCumulative with dividends | +56.3% | +76.7% |
| CAGR (3Y)Annualised 3-year return | +70.7% | +59.5% |
Risk & Volatility
Evenly matched — BMA and GGAL each lead in 1 of 2 comparable metrics.
Risk & Volatility
GGAL is the less volatile stock with a 1.73 beta — it tends to amplify market swings less than BMA's 1.76 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BMA currently trades 72.5% from its 52-week high vs GGAL's 66.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.76x | 1.73x |
| 52-Week HighHighest price in past year | $106.15 | $65.48 |
| 52-Week LowLowest price in past year | $38.30 | $25.89 |
| % of 52W HighCurrent price vs 52-week peak | +72.5% | +66.3% |
| RSI (14)Momentum oscillator 0–100 | 35.3 | 32.6 |
| Avg Volume (50D)Average daily shares traded | 364K | 1.2M |
Analyst Outlook
Evenly matched — BMA and GGAL each lead in 1 of 2 comparable metrics.
Analyst Outlook
Wall Street rates BMA as "Buy" and GGAL as "Buy". Consensus price targets imply 68.9% upside for BMA (target: $130) vs 39.3% for GGAL (target: $61). For income investors, GGAL offers the higher dividend yield at 6.85% vs BMA's 6.81%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $130.00 | $60.50 |
| # AnalystsCovering analysts | 14 | 12 |
| Dividend YieldAnnual dividend ÷ price | +6.8% | +6.8% |
| Dividend StreakConsecutive years of raises | 1 | 0 |
| Dividend / ShareAnnual DPS | $7302.65 | $4146.37 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.0% |
BMA leads in 2 of 6 categories (Income & Cash Flow, Total Returns). GGAL leads in 2 (Valuation Metrics, Profitability & Efficiency). 2 tied.
BMA vs GGAL: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is BMA or GGAL a better buy right now?
For growth investors, Grupo Financiero Galicia S.
A. (GGAL) is the stronger pick with -23. 5% revenue growth year-over-year, versus -33. 3% for Banco Macro S. A. (BMA). Grupo Financiero Galicia S. A. (GGAL) offers the better valuation at 5. 1x trailing P/E (0. 0x forward), making it the more compelling value choice. Analysts rate Banco Macro S. A. (BMA) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BMA or GGAL?
On trailing P/E, Grupo Financiero Galicia S.
A. (GGAL) is the cheapest at 5. 1x versus Banco Macro S. A. at 21. 1x. On forward P/E, Grupo Financiero Galicia S. A. is actually cheaper at 0. 0x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Grupo Financiero Galicia S. A. wins at 0. 00x versus Banco Macro S. A. 's 0. 00x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — BMA or GGAL?
Over the past 5 years, Banco Macro S.
A. (BMA) delivered a total return of +594. 5%, compared to +555. 7% for Grupo Financiero Galicia S. A. (GGAL). Over 10 years, the gap is even starker: GGAL returned +76. 7% versus BMA's +56. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BMA or GGAL?
By beta (market sensitivity over 5 years), Grupo Financiero Galicia S.
A. (GGAL) is the lower-risk stock at 1. 73β versus Banco Macro S. A. 's 1. 76β — meaning BMA is approximately 1% more volatile than GGAL relative to the S&P 500. On balance sheet safety, Banco Macro S. A. (BMA) carries a lower debt/equity ratio of 11% versus 36% for Grupo Financiero Galicia S. A. — giving it more financial flexibility in a downturn.
05Which is growing faster — BMA or GGAL?
By revenue growth (latest reported year), Grupo Financiero Galicia S.
A. (GGAL) is pulling ahead at -23. 5% versus -33. 3% for Banco Macro S. A. (BMA). On earnings-per-share growth, the picture is similar: Grupo Financiero Galicia S. A. grew EPS 119. 6% year-over-year, compared to -44. 6% for Banco Macro S. A.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BMA or GGAL?
Grupo Financiero Galicia S.
A. (GGAL) is the more profitable company, earning 15. 3% net margin versus 5. 0% for Banco Macro S. A. — meaning it keeps 15. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GGAL leads at 20. 8% versus 5. 6% for BMA. At the gross margin level — before operating expenses — BMA leads at 68. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BMA or GGAL more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Grupo Financiero Galicia S. A. (GGAL) is the more undervalued stock at a PEG of 0. 00x versus Banco Macro S. A. 's 0. 00x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Grupo Financiero Galicia S. A. (GGAL) trades at 0. 0x forward P/E versus 0. 0x for Banco Macro S. A. — 0. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BMA: 68. 9% to $130. 00.
08Which pays a better dividend — BMA or GGAL?
All stocks in this comparison pay dividends.
Grupo Financiero Galicia S. A. (GGAL) offers the highest yield at 6. 8%, versus 6. 8% for Banco Macro S. A. (BMA).
09Is BMA or GGAL better for a retirement portfolio?
For long-horizon retirement investors, Grupo Financiero Galicia S.
A. (GGAL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (6. 8% yield). Banco Macro S. A. (BMA) carries a higher beta of 1. 76 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (GGAL: +76. 7%, BMA: +56. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BMA and GGAL?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: BMA is a small-cap income-oriented stock; GGAL is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.